In 1987, Yeh et al. determined the concentration of TGF-α in the urine of HCC patients via RIA and found it to be significantly elevated, with a sensitivity of 71.7%, superior to serum AFP. The gene discussed is AFP; the disease is hepatocellular carcinoma.